Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Oct 31, 2025 | (FY)Apr 30, 2025 | (Q6)Oct 31, 2024 | (FY)Apr 30, 2024 | (Q6)Oct 31, 2023 | (FY)Apr 30, 2023 | (Q6)Oct 31, 2022 | (FY)Apr 30, 2022 | (Q6)Oct 31, 2021 | (FY)Apr 30, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 4.27%161.01M | 14.75%301.45M | 16.48%154.41M | -16.05%262.7M | -20.40%132.57M | -35.88%312.93M | -29.43%166.55M | 32.51%488.05M | 43.87%236.01M | 34.14%368.32M |
| Operating income | 4.27%161.01M | 14.75%301.45M | 16.48%154.41M | -16.05%262.7M | -20.40%132.57M | -35.88%312.93M | -29.43%166.55M | 32.51%488.05M | 43.87%236.01M | 34.14%368.32M |
| Operating expenses | ||||||||||
| Gross profit | ||||||||||
| Profit from asset sales | --119K | 408.33%814K | ---- | -494.03%-264K | -494.03%-264K | -88.47%67K | -87.91%67K | 174.06%581K | 4,936.36%554K | 110.26%212K |
| Employee expense | -1.14%-51.63M | -0.43%-99.29M | -8.61%-51.05M | 5.67%-98.86M | -9.63%-47M | 16.84%-104.81M | 27.85%-42.87M | -19.37%-126.03M | -42.96%-59.42M | -33.19%-105.58M |
| Depreciation and amortization | 27.79%-5.07M | 23.61%-9.89M | 19.76%-7.02M | 40.90%-12.94M | 35.45%-8.74M | -0.08%-21.9M | -22.49%-13.55M | -15.66%-21.88M | -13.65%-11.06M | 32.13%-18.92M |
| Revaluation surplus | 532.05%60.31M | 81.07%-4.17M | 187.49%9.54M | 19.31%-22M | -135.72%-10.91M | -259.23%-27.26M | 9.57%30.54M | 134.98%17.12M | 350.43%27.87M | 164.03%7.29M |
| -Changes in the fair value of derivative financial instruments | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---696K |
| -Changes in the fair value of financial assets | 532.05%60.31M | 81.07%-4.17M | 187.49%9.54M | 19.31%-22M | -135.72%-10.91M | -259.23%-27.26M | 9.57%30.54M | 114.50%17.12M | 350.43%27.87M | 170.15%7.98M |
| Impairment and provision | ---- | 74.78%-5.33M | ---- | -74.51%-21.12M | ---- | 22.45%-12.1M | ---- | ---15.61M | ---- | ---- |
| -Other impairment is provision | ---- | 74.78%-5.33M | ---- | -74.51%-21.12M | ---- | 22.45%-12.1M | ---- | ---15.61M | ---- | ---- |
| Special items of operating profit | 9.27%-83.12M | -9.17%-182.22M | -8.47%-91.61M | 6.16%-166.92M | 22.42%-84.46M | 46.00%-177.88M | 35.74%-108.87M | -31.07%-329.43M | -59.89%-169.4M | -26.70%-251.35M |
| Operating profit | 471.70%81.62M | 102.32%1.38M | 175.90%14.28M | -91.93%-59.41M | -159.02%-18.81M | -341.66%-30.95M | 29.83%31.87M | 64,140.00%12.81M | 668.30%24.55M | 99.97%-20K |
| Financing cost | -4.35%-719K | 10.25%-1.3M | 6.00%-689K | 18.55%-1.45M | 2.91%-733K | -18.38%-1.78M | 14.59%-755K | 26.77%-1.51M | -12.90%-884K | -4.63%-2.06M |
| Share of profits of associates | ---24K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Special items of earning before tax | -11.82%-2.04M | -25.34%-554K | -135.14%-1.83M | 47.57%-442K | -125.87%-777K | -78.22%-843K | 150.46%3M | 95.16%-473K | 206.96%1.2M | -360.38%-9.77M |
| Earning before tax | 570.32%78.83M | 99.22%-480K | 157.88%11.76M | -82.55%-61.3M | -159.56%-20.32M | -410.11%-33.58M | 37.23%34.12M | 191.41%10.83M | 499.49%24.86M | 82.41%-11.85M |
| Tax | -87.00%-935K | -520.21%-583K | ---500K | 87.30%-94K | ---- | -1.93%-740K | -2,886.96%-687K | -101.67%-726K | 96.70%-23K | 55.45%-360K |
| After-tax profit from continuing operations | 591.79%77.9M | 98.27%-1.06M | 155.42%11.26M | -78.89%-61.39M | -160.78%-20.32M | -439.72%-34.32M | 34.59%33.43M | 182.77%10.1M | 458.97%24.84M | 82.09%-12.21M |
| Earning after tax | 591.79%77.9M | 98.27%-1.06M | 155.42%11.26M | -78.89%-61.39M | -160.78%-20.32M | -439.72%-34.32M | 34.59%33.43M | 182.77%10.1M | 458.97%24.84M | 82.09%-12.21M |
| Profit attributable to shareholders | 591.79%77.9M | 98.27%-1.06M | 155.42%11.26M | -78.89%-61.39M | -160.78%-20.32M | -439.72%-34.32M | 34.59%33.43M | 182.77%10.1M | 458.97%24.84M | 82.09%-12.21M |
| Basic earnings per share | 531.28%0.2462 | 98.26%-0.0037 | 155.40%0.039 | -59.85%-0.2126 | -148.48%-0.0704 | -382.98%-0.133 | 19.70%0.1452 | 172.42%0.047 | 429.62%0.1213 | 82.09%-0.0649 |
| Diluted earnings per share | 531.28%0.2462 | 98.26%-0.0037 | 155.40%0.039 | -59.85%-0.2126 | -148.48%-0.0704 | -431.67%-0.133 | 19.70%0.1452 | 161.79%0.0401 | 429.62%0.1213 | 82.09%-0.0649 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Evergreen (Hong Kong) Certified Public Accountants Limited | -- | Guowei Certified Public Accountants Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.